1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
|
1.1|9|11|95|1pter-p36.13|CCV|P|Cataract, congenital, Volkmann type||115665|Fd|linked to Rh in Scottish family||Cataract, congenital, Volkmann type (2)| | ||
1.2|9|25|01|1pter-p36.13|ENO1, PPH, MPB1|C|Enolase-1, alpha||172430|S, F, R, REa|||Enolase deficiency (1)| | |4(Eno1)|
1.3|10|23|87|1pter-p36.13|GDH|C|Glucose dehydrogenase||138090|S, F|||| | ||
1.3|10|23|87|1pter-p36.14|gene-symbol1|C|XXX||100500|M method 1|comment1||| | |mousecorrelate1|
1.3|10|23|87|1pter-p36.15|gene-symbol2|C|XXX||100501|M method 2|comment2||| | |mousecorrelate2|
1.4|6|7|99|1pter-p36.1|CTPP, CPP, CTPA|P|Cataract, posterior polar||116600|Fd|?relation to Volkmann cataract||Cataract, posterior polar (2)| | ||
1.5|12|22|87|1pter-p36|ERPL1, HLM2|C|Endogenous retroviral pol gene-like sequence 1 (oncogene HLM2)||131190|REa, F|||| | ||
1.6|1|18|95|1pter-p33|HMGCL|P|3-hydroxy-3-methylglutaryl-Coenzyme A lyase||246450|REa, A|||HMG-CoA lyase deficiency (3)| | |4(Hmgcl)|
1.7|12|16|93|1pter-p32|AGRN|P|Agrin||103320|REa|||| | |4(Agrn)|
1.8|3|15|92|1pter-p31.2|GNB1|C|Guanine nucleotide-binding protein, beta polypeptide-1||139380|REa, A|||| | |4(Gnb1)|
1.9|8|28|98|1pter-p22.1|SAI1, MTS1, TFS1|C|Suppression of anchorage independence-1 (malignant transformation|suppression-1)|154280|S, H|||| | |4(Tfs1)|
1.10|4|24|01|1p36.33|TAS1R3, T1R3|P|Taste receptor type 1, member 3||605865|REn|||| | |4(Tas1r3)|
1.11|10|27|89|1p36.33-p36.22|CA6|C|Carbonic anhydrase VI||114780|REa, A, REc, R|||| | ||
1.12|8|9|99|1p36.3|C1orf1|P|Chromosome 1, open reading frame 1||604006|A|||| | ||
1.13|12|1|98|1p36.3|CDC2L1|C|Cell division cycle 2-like 1||176873|REa, A, Pcm, A|||| | ||
1.14|12|1|98|1p36.3|CDC2L2|P|Cell division cycle 2-like 2||116951|A|||| | ||
1.15|8|4|99|1p36.3|DFFB, CAD, DFF2|C|DNA fragmentation factor, 40kD, beta subunit||601883|A|||| | ||
1.16|11|5|99|1p36.3|EGFL3, MEGF6|P|Epidermal growth factor-like 3||604266|R|||| | ||
1.17|1|24|01|1p36.3|GABRD|C|Gamma-aminobutyric acid (GABA) A receptor, delta||137163|REa, R|||| | ||
1.18|9|12|96|1p36.3|HKR3|C|GLI-Kruppel family member HKR3||165270|REa, A|||| | ||
1.19|6|15|99|1p36.3|TNFRSF18, AITR, GITR|P|Tumor necrosis factor receptor superfamily, member 18||603905|R|||| | ||
1.20|3|30|99|1p36.3|KCNAB2, KCNA2B|P|Potassium voltage-gated channel, shaker-related subfamily, beta|member 2|601142|A|||| | ||
1.21|11|1|99|1p36.3|MMP23A, MMP21, MIFR|P|Matrix metalloproteinase 23A||603320|REc|||| | ||
1.22|11|1|99|1p36.3|MMP23B, MMP22|P|Matrix metalloproteinase 23B||603321|REc|||| | ||
1.23|10|4|93|1p36.3|MTHFR|P|Methylenetetrahydrofolate reductase||236250|A|||Homocystinuria due to MTHFR deficiency (3)| | |4(Mthfr)|
1.24|1|17|01|1p36.3|PRDM16, MEL1|P|PR domain-containing protein 16||605557|REc, Ch|||| | ||
1.25|8|9|99|1p36.3|PTPRZ2|P|Protein-tyrosine phosphatase, receptor-type, zeta-2||604008|A|||| | ||
1.26|1|20|98|1p36.3|RNU1A, RNU1|C|RNA, U1A small nuclear||180680|REa, A|?same as A12M2||| | |3(Rnu1b1)|
1.27|12|21|98|1p36.3|TNFRSF12, DR3, LARD|C|Tumor necrosis factor receptor superfamily, member 12||603366|A, Ch|||| | ||
1.28|6|20|01|1p36.3|WDR8|P|WD repeat-containing protein 8||606040|A|||| | ||
1.29|8|9|99|1p36.3|XBX1|P|Xylan 1,4-beta-xylosidase 1||604007|A|||| | ||
1.30|2|6|94|1p36.3-p34.3|HTR1D|C|5-hydroxytryptamine (serotonin) receptor-1D||182133|REa, A|||| | |4(Htr1d)|
1.31|6|10|98|1p36.3-p36.2|DFFA, DFF1|C|DNA fragmentation factor, 45kD, alpha subunit||601882|A|||| | ||
1.32|1|30|01|1p36.3-p36.2|MASP2|P|Mannan-binding lectin serine protease 2||605102|A, R|||| | ||
1.33|7|4|95|1p36.3-p36.2|NB, NBS|C|Neuroblastoma (neuroblastoma suppressor)||256700|Ch, D|?role of DAN||Neuroblastoma (2)| | ||
1.34|1|1|95|1p36.3-p36.2|PLOD, PLOD1|P|Procollagen-lysine, 2-oxoglutarate 5-dioxygenase (lysine hydroxylase)||153454|REa, A|||Ehlers-Danlos syndrome, type VI, 225400 (3)| | |4(Plod)|Hautala (1992)
1.35|9|15|96|1p36.3-p36.2|SCNN1D|P|Sodium channel, voltage-gated, type I, delta polypeptide||601328|A|||| | ||
1.36|12|18|98|1p36.3-p36.2|TNFRSF1B, TNFR2, TNFBR|C|Tumor necrosis factor receptor superfamily, member 1B||191191|REa, A, Fd|||| | |4(Tnfr1)|
1.37|12|14|98|1p36.3-p36.2|TNFRSF14, HVEM, TR2|P|Tumor necrosis factor receptor superfamily, member 14 (herpesvirus|entry mediator)|602746|A|||| | ||
1.38|11|18|96|1p36.3-p34.1|C1QA|C|Complement component-1, q subcomponent, alpha polypeptide||120550|REa, REb|||C1q deficiency, type A (3)| | ||
1.39|11|18|96|1p36.3-p34.1|C1QB|C|Complement component-1, q subcomponent, beta polypeptide||120570|REa, REb|||C1q deficiency, type B (3)| | |(C1qb)|
1.40|11|18|96|1p36.3-p34.1|C1QG|P|Complement component-1, q subcomponent, gamma polypeptide||120575|REn, REb|||C1q deficiency, type C (3)| | ||
1.41|6|18|97|1p36.2|FRAP1|P|FK506 binding protein 12-rapamycin associated protein-1||601231|R, A|||| | ||
1.42|12|11|01|1p36.2|KIF1B, CMT2A|C|Kinesin family member 1B||605995|Fd, REc, D|||Charcot-Marie-Tooth neuropathy, type 2A, 118210 (3)| | |4(Kif1b)|
1.43|6|2|94|1p36.2|NPPA, PND, ANP|C|Pronatriodilatin (atrial natriuretic peptide)||108780|REa, A, H|||| | |4(Pnd)|
1.44|5|9|95|1p36.2|NPPB, BNP|C|Natriuretic peptide precursor B||600295|H, REa, A, REn|||| | |4(Nppb)|
1.45|8|4|99|1p36.2|SLC2A5, GLUT5|C|Solute carrier family 2 (facilitated glucose transporter), member 5||138230|REa, A, REc, R|||| | ||
1.46|4|10|90|1p36.2-p36.13|PGD|C|6-phosphogluconate dehydrogenase||172200|F, S|||| | |4(Pgd)|
1.47|2|19|96|1p36.2-p36.12|PAX7|C|Paired box homeotic gene-7||167410|Psh, H, REa, A|fused with FKHR in rhabdomyosarcoma||Rhabdomyosarcoma, alveolar, 268220 (3)| | |4(Pax7)|
1.48|4|19|01|1p36.2-p36.1|DNB5|P|Deleted in neuroblastoma 5||605763|REc|||| | ||
1.49|3|24|88|1p36.2-p36.1|FGR, SRC2|P|Oncogene FGR||164940|A, REb, REa, Fd|same as SRC2||| | |4(Fgr)|
1.50|9|22|97|1p36.2-p36.1|GLC3B|P|Glaucoma 3, primary infantile, B||600975|Fd|||Glaucoma 3, primary infantile, B (2)| | ||
1.51|9|7|00|1p36.2-p36.1|RERE|P|RE repeats-encoding gene||605226|REc, Ch|||| | ||
1.52|6|19|00|1p36.2-p36.1|ZNF151|P|Zinc finger protein-151||604084|A|||| | ||
1.53|1|1|95|1p36.2-p35|CDA|C|Cytidine deaminase||123920|A, Psh|||| | ||
1.54|10|22|92|1p36.2-p34|EPB41, EL1|C|Erythrocyte surface protein band 4.1||130500|F, REb|||Elliptocytosis-1 (3)| | |4(Elp1)|
1.55|10|23|87|1p36.2-p34|RD|C|Radin blood group||111620|F|||| | ||
1.56|8|4|97|1p36.2-p34|RHCE|C|Rhesus system C and E polypeptides||111700|F, D, Fd|?order: C-E-D||| | ||
1.57|1|10|89|1p36.2-p34|RHD|C|Rhesus system D polypeptide||111680|F, D, Fd|||| | ||
1.58|10|23|87|1p36.2-p34|SC|C|Scianna blood group||111750|F|||| | ||
1.59|10|18|00|1p36.2-p34|SMP1|P|Small membrane protein 1||605348|REc|between RHD and RHCE||| | ||
1.60|1|11|95|1p36.13-p36.12|ID3|C|Inhibitor of DNA binding 3, dominant negative, helix-loop-helix|protein|600277|RE, A|||| | ||
1.61|10|24|97|1p36.13-p36.11|D1S1733E, DAN|P|Differential-screening-selected gene aberrant in neuroblastoma||600613|A|aberrant in some neuroblastomas||| | |4(D4H1S1733E)|
1.62|3|1|01|1p36.12|PLA2G2D, SPLASH|C|Phospholipase A2, group IID||605630|R|||| | |4(Pla2g2d)|
1.63|4|24|01|1p36.11-p34.3|WASF2, WAVE2, SCAR2|P|Wiskott-Aldrich syndrome protein family, member 2||605875|REc|?pseudogene on Xp11.21||| | ||
1.64|8|18|99|1p36.1-p35|C1orf4, B120|P|Brain protein 120||603024|A|||| | ||
1.65|8|28|97|1p36.1|CAPZB, CAPPB|P|Capping protein (actin filament) muscle Z-line, beta||601572|A|||| | ||
1.66|10|20|99|1p36.1|CDC42|P|Cell division cycle 42 (GTP-binding protein, 25kD)||116952|H, R, REc|||| | |4(cdc42)|
1.67|1|1|95|1p36.1|CHC1, RCC1|C|Regulator of chromosome condensation||179710|REb, A|||| | |4(Chc1)|
1.68|5|28|98|1p36.1|DDOST, OST, OST48|P|Dolichyl-diphosphooligosaccharide-protein glycosyltransferase||602202|A|||| | ||
1.69|6|16|99|1p36.1|ECE1|C|Endothelin converting enzyme 1||600423|A, R, Psh|||Hirschsprung disease, cardiac defects, and autonomic dysfunction (3)| | ||
1.70|5|5|98|1p36.1|EPHA2, ECK|P|Ephrin receptor EphA2||176946|A, REa|||| | |4(Epha2)|
1.71|4|11|97|1p36.1|EXTL1|P|Exostosin-like 1||601738|R, A|||| | ||
1.72|10|12|90|1p36.1|HMG17|C|Nonhistone chromosomal protein HMG-17||163910|REa, A|||| | ||
1.73|4|1|01|1p36.1|HSPG2, PLC, SJS, SJA, SJS1|C|Heparan sulfate proteoglycan of basement membrane (perlecan)||142461|A, REa, LD|||Schwartz-Jampel syndrome, type 1, 255800 (3); Dyssegmental dysplasia,|Silverman-Handmaker type, 224410 (3) | |4(Plc)|
1.74|3|6|01|1p36.1|NR0B2, SHP|P|Nuclear receptor subfamily 0, group B, member 2||604630|REa, A|||Obesity, mild, early-onset, 601665 (3)| | ||
1.75|8|21|91|1p36.1|PRKACB|P|Protein kinase, cAMP-dependent, catalytic, beta||176892|REa, A|||| | ||
1.76|11|3|98|1p36.1|RNU17A, RNE1|C|RNA, U17a small nucleolar||180645|REn|in IVS1 of CHC1||| | ||
1.77|11|3|98|1p36.1|RNU17B|P|RNA, U17b small nucleolar||603239|REn|||| | ||
1.78|12|15|99|1p36.1|RNU17D, U17HG|P|RNA, U17d small nucleolar||603238|REn|||| | ||
1.79|2|20|98|1p36.1|RSC1A1, RS1|P|Regulatory solute carrier protein, family 1, member 1||601966|A|||| | ||
1.80|2|15|96|1p36.1|TCEB3|P|Transcription elongation factor B (SIII), polypeptide 3 (110kD,|elongin A)|600786|A|||| | ||
1.81|9|13|89|1p36.1|TRN|P|tRNA asparagine||189880|REa, RE|||| | ||
1.82|11|5|97|1p36.1-p35|EPHB2, EPHT3, DRT, ERK|P|eph tyrosine kinase 3 (ephrin receptor EphB2)||600997|Psh, A|||| | ||
1.83|4|23|96|1p36.1-p35|MEMO1|P|Methylation modifier for class I HLA||601201|D|||| | ||
1.84|10|22|95|1p36.1-p35|MFAP2, MAGP, MAGP1|P|Microfibrillar-associated protein-2||156790|REa, A|||| | |4(Mfap2)|
1.85|2|26|95|1p36.1-p35|RAP1GA1|P|RAP1, GTPase activating protein 1||600278|A, REa|||| | ||
1.86|10|20|99|1p36.1-p35|RPL11|C|Ribosomal protein L11||604175|REa, R, A|||| | ||
1.87|11|28|01|1p36.1-p35|SDHB, SDH1, SDHIP|C|Succinate dehydrogenase complex, subunit B, iron sulfur (Ip)||185470|S, REa, A|1 of 2 polypeptides||Pheochromocytoma, extraadrenal, and cervical paraganglioma, 115310|(3) | ||
1.88|3|28|95|1p36.1-p35|SLC9A1, NHE1, APNH|C|Solute carrier family 9 (sodium/hydrogen exhanger), isoform 1|(antiporter, Na+/H+, amiloride sensitive)|107310|A, F, Fd|3cM proximal to RH||| | |4(Apnh, Nhe1)|
1.89|7|17|01|1p36.1-p35|STMN1, LAP18, SMN|P|Stathmin||151442|REa, A|||| | |4(Lap18)|
1.90|1|1|95|1p36.1-p34.3|GPR3|C|G protein-coupled receptor-3||600241|A|||| | ||
1.91|3|17|94|1p36.1-p34.3|OPRD1|P|Opioid receptor, delta-1||165195|H, A|||| | |4(Nbor, Oprd1)|
1.92|6|15|99|1p36.1-p34|ALPL, HOPS|C|Alkaline phosphatase, liver/bone/kidney||171760|S, H, Fd, F, A|||Hypophosphatasia, infantile, 241500 (3); Hypophosphatasia, childhood,|241510 (3); ?Hypophosphatasia, adult, 146300 (1) | |4(Akp2)|
1.93|1|25|99|1p36|ALDH4A1, ALDH4, P5CDH|P|Aldehyde dehydrogenase 4 family, member A1|(delta-1-pyrroline 5-carboxylate dehydrogenase)|606811|A|||Hyperprolinemia, type II, 239510 (3)| | ||
1.94|5|14|02|1p36|BMND3|P|Bone mineral density variability 3||606928|Fd|||[Bone mineral density variability 3], 601884 (2)| | ||
1.95|10|2|89|1p36|BRCD2|P|Breast cancer, ductal||211420|Ch, F, D|||Breast cancer, ductal (2)| | ||
1.96|6|19|98|1p36|CLCN6|P|Chloride channel 6||602726|REa, A|||| | ||
1.97|10|15|97|1p36|CLCNKA|C|Chloride channel, kidney, A||602024|Fd, REc|11kb from CLCNKB||| | ||
1.98|10|15|97|1p36|CLCNKB|C|Chloride channel, kidney, B||602023|Fd, REc|unequal crossingover with CLCNKA||Bartter syndrome, antenatal, 601678 (3); Bartter syndrome, 241200 (3)| | ||
1.99|1|4|93|1p36|CMM, MLM, DNS|P|Cutaneous malignant melanoma/dysplastic nevus||155600|F, Fd, D|some linkage studies negative; see 9p||Malignant melanoma, cutaneous (2)| | ||Greene (1983); Goldstein (1992)
1.100|8|15|96|1p36|DVL1|C|Dishevelled 1 (homologous to Drosophila dsh)||601365|Psh, A|||| | ||
1.101|2|01|01|1p36|CORT|C|Cortistatin||602784|H, R, REc|||| | |4(Cort)|
1.102|2|23|95|1p36|E2F2|P|E2F transcription factor 2||600426|A|||| | ||
1.103|4|18|97|1p36|EYA3|P|Eyes absent, Drosophila, homolog of, 3||601655|A, H|||| | |4(Eya3)|
1.104|9|7|00|1p36|IBD7|P|Inflammatory bowel disease-7||605225|Fd|||{Inflammatory bowel disease-7}, 266600 (2)| | ||
1.105|4|17|01|1p36|ICMT|P|Isoprenylcysteine carboxylmethyltransferase||605851|R|||| | ||
1.106|2|15|02|1p36|KRPPD|P|Kufor-Rakeb pallidopyramidal degeneration with supranuclear upgaze|paresis and dementia|606693|Fd|||Kufor-Rakeb syndrome (2)| | ||
1.107|4|2|01|1p36|LUZP1|P|Leucine zipper protein 1||601422|H, R|||| | |4(Luzp)|
1.108|3|9|00|1p36|MAD2L2, MAD2B|P|Mitotic arrest-deficient 2, S. cerevisiae, homolog-like 2||604094|R|pseudogene on 14q21-q23||| | ||
1.109|6|3|02|1p36|PARK7|P|Parkinson disease 7, autosomal recessive early-onset||606324|Fd|||Parkinson disease, 168600 (2)| | ||
1.110|4|21|99|1p36|PCBC, CAPB|P|Prostate cancer-brain cancer susceptibility||603688|Fd|||{Prostate cancer-brain cancer susceptibility} (2)| | ||
1.111|9|28|96|1p36|PRDM2, RIZ|P|PR domain-containing protein 2 (retinoblastoma protein-binding|zinc-finger protein RIZ)|601196|REc, A|||| | |4(Riz)|
1.112|11|29|99|1p36|RUNX3, CBFA3, PEBP2A3, AML2|C|Runt-related transcription factor 3||600210|A, REa|||| | |4(Aml2, Cbfa3)|
1.113|12|18|98|1p36|TNFRSF4, TXGP1L, OX40, ACT35|P|Tumor necrosis factor receptor superfamily, member 4||600315|A|||| | |4(Ox40)|
1.114|12|18|98|1p36|TNFRSF8, CD30, D1S166E|P|Tumor necrosis factor receptor superfamily, member 8|(CD30 antigen; Ki-1 antigen)|153243|A|||| | |4(Cd30)|
1.115|12|18|98|1p36|TNFRSF9, ILA, CD137|P|Tumor necrosis factor receptor superfamily, member 9|(interleukin-activated receptor; Ly63, mouse, homolog of)|602250|REa|||| | |(Cd157)|
1.116|10|15|97|1p36|TP73|P|p53-related protein||601990|D|imprinted||?Neuroblastoma (1)| | ||
1.117|9|13|89|1p36|TRE|P|tRNA glutamic acid||180640|A|||| | ||
1.118|6|12|01|1p36-p35|ARH, FHCB2, FHCB1|P|Autosomal recessive hypercholesterolemia gene||605747|Fd|||Hypercholesterolemia, familial, autosomal recessive, 603813 (3)| | ||
1.119|5|29|02|1p36-p35|GALE|C|UDP galactose-4-epimerase||606953|S, LD|||Galactose epimerase deficiency, 230350 (3)| | ||
1.120|3|12|96|1p36-p35|HTR6|P|5-hydroxytryptamine (serotonin) receptor-6||601109|REa|||| | ||
1.121|6|18|01|1p36-p35|PARK6|P|Parkinson disease 6, autosomal recessive early-onset||605909|Fd|||Parkinson disease, 168600 (2)| | ||
1.122|8|23|01|1p36-p35|SEPN1, SELN, RSMD1|C|Selenoprotein N||606210|REc, Fd|||Muscular dystrophy, rigid spine, 1, 602771 (3)| | ||
1.123|1|26|97|1p36-p34.1|SCCD|P|Schnyder crystalline corneal dystrophy||121800|Fd|||Corneal dystrophy, crystalline, Schnyder (2)| | ||
1.124|3|9|98|1p36-p34|PLA2G5|P|Phospholipase A2, group V||601192|A|||| | |4(Pla2g5)|
1.125|5|4|00|1p36-p32|PABPC4, PABP4, IPABP, APP1|P|Polyadenylate-binding protein, cytoplasmic, 4||603407|Psh, R|||| | ||
1.126|12|3|91|1p36-p22|SRM, SPS1|C|Spermidine synthase-1||182891|REa, A, Psh|?pseudogene on 3p14-q21||| | ||
1.127|8|9|01|1p35.2-p33|DSCR1L2, MCIP3|P|Down syndrome critical region gene 1-like 2 (myocyte-enriched|calcineurin-interacting protein 3)|605860|REc|||| | |4(Dscr1l2)|
1.128|2|18|96|1p35.1|GJA4, CX37|C|Gap junction protein, alpha-4, 37kD (connexin 37)||121012|REa, A, REc|||| | |(Gja4)|
1.129|12|28|01|1p35.1|GJB3, CX31, DFNA2|C|Gap junction protein, beta-3||603324|REn, REc, Psh, A|same YAC as GJA4||Erythrokeratodermia variabilis, 133200 (3); Deafness, autosomal|dominant 2, 600101 (3); Deafness, autosomal recessive (3); Deafness, autosomal dominant, with peripheral neuropathy (3)| ||
1.130|11|29|00|1p35.1|GJB4, CX30.3|P|Gap junction protein, beta-4||605425|REn, Fd|||Erythrokeratodermia variabilis with erythema gyratum repens,|133200 (3) | ||
1.131|11|29|00|1p35.1|GJB5, CX31.1|P|Gap junction protein, beta-5||604493|R, REc|||| | ||
1.132|12|2|97|1p35.1|P28|P|Inner dynein arm, clamydomonas, homolog of||602135|REa, R|||| | ||
1.133|6|10|98|1p35|BAI2|P|Brain-specific angiongenesis inhibitor-2||602683|A|||| | ||
1.134|8|21|91|1p35|EBVS1|P|Epstein-Barr virus integration site||132850|A|||| | ||
1.135|3|21|93|1p35|G1P3, IFI616|C|Interferon, alpha-inducible protein (clone IFI-6-16)||147572|A, T|||| | ||
|
